The Efficacy and Safety of Efsubaglutide Alfa Injection in Overweight and Obese Subjects (ENLIGHT)
Clinical trial NCT06921486 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06921486
- Sponsor
- Shanghai Yinnuo Pharmaceutical Technology Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-31
- Primary completion
- 2026-08-31
- Enrollment
- 1003
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.